Latin America Annual Meeting

Innovative clinical trial designs are transforming the way we generate evidence by making studies more adaptive, efficient, and patient-centric. In Latin America, the adoption of methodologies such as platform trials, master protocols, adaptive designs, and decentralized clinical trials (DCTs) is gaining traction—offering opportunities to accelerate access to innovative therapies and strengthen regional research capabilities.

This session will feature a range of perspectives—including regulators, clinical operations experts, and academic leaders—who will present case studies and experiences implementing innovative designs in the region. Topics will include how flexible methodologies have been applied to real-world clinical research in oncology and rare diseases, the evolving regulatory landscape supporting these approaches, and lessons learned in managing operational complexity and ethical oversight.

Attendees will also explore how stakeholder collaboration, digital tools, and infrastructure development are critical enablers for the wider adoption of these models. The session will conclude with a dialogue on how Latin America can enhance its readiness and leadership in the global transition toward smarter, more resilient clinical research frameworks.